EUCTR2018-001016-30-AT进行中（未招募）1 期
PROSPECTIVE STUDY OF 68GA-NODAGA-RGD-PET FOR THE NON-INVASIVE DETERMINAITON OF THE INTEGRIN avß3 EXPRESSION IN PATIENTS WITH UNTREATED OR RECURRENT BREAST CANCER, COLORECTAL CANCER, NON-SMALL CELL LUNG CANCER OR NEUROENDOCRINE TUMORS - 68Ga-NODAGA-RGD-PET for tumor imaging
Department of Nuclear Medicine, Medical University Innsbruck0 个研究点目标入组 24 人开始时间: 2018年7月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Untreated breast cancer, non-small cell lung cancer, colorectal cancer and neuroendocrine tumors
- •Written informed consent
- •Age 18 or above
- •In women, pregnancy must be excluded and contraception must be performed
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 18
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 6
排除标准
- •Karnovsky Index <75%
- •Advanced renal insufficiency with an eGFR below 30 ml/min
- •Pregnancy or nursing period
研究者
相似试验
进行中（未招募）
1 期
[68GA]NODAGA-RGD-PET FOR THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA AND THE ASSESSMENT OF TREATMENT RESPONSEThis trial investigates a new tracer substance for PET scan of hepatocellular carcinoma in patients with liver disease. The condition investigated is a hepatocellular carcinoma in patients with liver cirrhosis. In a subset of patients, the PET scan will be repeated during tumor specific therapies to evaluate changes in tracer accumulation after therapy.EUCTR2013-003741-42-ATMedizinische Universität Innsbruck, Abteilung für Nuklearmedizin30
进行中（未招募）
不适用
A prospective study of the use of 68Ga-DOTA-TATE PET/CT in patients with neuroendocrine tumors.Patients with neuroendocrine tumors, who are going to be diagnosed/evaluated with 68Ga-DOTA-TATE PET/CT instead of standard OctreoscanMedDRA version: 14.1Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 100000004864EUCTR2012-004313-13-SESkåne University Hospital, Dept of Oncology450
终止
1 期
68Ga-NODAGA-RGD PET/ CT for Tumoral NeoangiogenesisPathological AngiogenesisNCT02666547University of Lausanne Hospitals42
Unknown
早期 1 期
68Ga-NOTA-PRGD2 PET/CT in Patients With Lung Injury and Pulmonary FibrosisPulmonary Fibrosis, UnspecifiedNCT02511197Peking Union Medical College Hospital30
进行中（未招募）
不适用
se of 68Ga-DOTA-NOC for the evaluation of patients with Idiopathic pulmonary fibrosisSTUDY CODE: 68Ga-DOTA-NOC/ILD 01/2008 - 68Ga-DOTA-NOC/ILD01/2008EUCTR2008-007168-40-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI